Beta Bionics, Inc. (BBNX) — Financial statements
Income statement, balance sheet, and cash flow for Beta Bionics, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Revenue & Gross Profit | |||||
| Revenue | 100↑53.9% | 65↑442.9% | 12↑6601.1% | 0.18 | |
| Cost of Revenue | 45↑52.9% | 29↑414.1% | 6 | 0.00 | |
| Gross Profit | 56↑54.8% | 36↑468.9% | 6↑3424.0% | 0.18 | |
| Operating Expenses | |||||
| R&D Expenses | 35↑32.9% | 26↑45.9% | 18↓42.9% | 31 | |
| General & Administrative Expenses | 31↑73.6% | 18↑46.2% | 12↓50.4% | 25 | |
| Selling & Marketing Expenses | 61↑65.6% | 37↑209.3% | 12↑35.8% | 9 | |
| SG&A Expenses | 92↑68.2% | 55↑126.9% | 24↓27.7% | 33 | |
| Other Expenses | 0.00 | 0.00 | 0.00↓100.0% | 1 | |
| Operating Expenses | 127↑56.8% | 81↑92.5% | 42↓36.1% | 66 | |
| Total Costs & Expenses | 172↑55.8% | 110↑130.7% | 48↓27.5% | 66 | |
| Operating Results | |||||
| Operating Income | -72↓58.4% | -45↓26.2% | -36↑45.6% | -66 | |
| Depreciation & Amortization | 0.00↓100.0% | 1↓6.1% | 1↓8.8% | 1 | |
| EBITDA | -73↓66.0% | -44↓27.4% | -35↑45.4% | -63 | |
| EBIT | -73↓61.8% | -45↓26.2% | -36↑44.6% | -65 | |
| Interest & Other Income | |||||
| Net Interest Income | 11↑179.7% | 4↑120.0% | 2↑876.4% | 0.18 | |
| Interest Income | 11↑179.7% | 4↑120.0% | 2↑806.6% | 0.20 | |
| Interest Expense | 0.00 | 0.00 | 0.00↓100.0% | 0.01 | |
| Non-Operating Income | 2 | 0.00 | 0.00↑100.0% | -1 | |
| Other Income / Expenses | -2↑84.0% | -10↓15.2% | -8↓854.7% | 1 | |
| Income Before Tax | -73↓33.7% | -55↓24.2% | -44↑31.9% | -65 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | |||||
| Net Income from Continuing Operations | -73↓33.7% | -55↓24.2% | -44↑31.9% | -65 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -73↓33.7% | -55↓24.2% | -44↑31.9% | -65 | |
| Bottom-Line Net Income | -73↓33.7% | -55↓24.2% | -44↑31.9% | -65 | |
| EPS (Basic) | -1.81↑79.0% | -8.60↓3.5% | -8.31↑35.9% | -12.96 | |
| EPS (Diluted) | -1.81↑79.0% | -8.60↓3.5% | -8.31↑35.9% | -12.96 | |
| Weighted Average Shares | 41↑536.7% | 6↑20.0% | 5↑6.1% | 5 | |
| Weighted Average Diluted Shares | 41↑536.7% | 6↑20.0% | 5↑6.1% | 5 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.